New recombinant cell line from Crown Bioscience
Crown Bioscience (CrownBio), Crown Bioscience International’s wholly owned subsidiary and a worldwide development services company, recently launched its own six new recombinant cell lines dedicated to drug screening, biological studies, development, and discovery. Read More »
Alerts Sign-up